Abstract
In this issue of Blood, Collins et al provide the results of a prospective, randomized, single-blind, phase 3 trial on the use of nonacog beta pegol, a new long-acting glycoPEGylated factor IX (FIX) molecule for the treatment and prevention of bleeding episodes in 74 patients with hemophilia B.
| Original language | English |
|---|---|
| Pages (from-to) | 3836-3837 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 124 |
| Issue number | 26 |
| DOIs | |
| Publication status | Published - Dec 18 2014 |
Fingerprint
ASJC Scopus subject areas
- Hematology
- Biochemistry
- Cell Biology
- Immunology
- Medicine(all)
Cite this
GlycoPEGylated factor IX : A new step forward. / Mancuso, Maria Elisa.
In: Blood, Vol. 124, No. 26, 18.12.2014, p. 3836-3837.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - GlycoPEGylated factor IX
T2 - A new step forward
AU - Mancuso, Maria Elisa
PY - 2014/12/18
Y1 - 2014/12/18
N2 - In this issue of Blood, Collins et al provide the results of a prospective, randomized, single-blind, phase 3 trial on the use of nonacog beta pegol, a new long-acting glycoPEGylated factor IX (FIX) molecule for the treatment and prevention of bleeding episodes in 74 patients with hemophilia B.
AB - In this issue of Blood, Collins et al provide the results of a prospective, randomized, single-blind, phase 3 trial on the use of nonacog beta pegol, a new long-acting glycoPEGylated factor IX (FIX) molecule for the treatment and prevention of bleeding episodes in 74 patients with hemophilia B.
UR - http://www.scopus.com/inward/record.url?scp=84919493189&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84919493189&partnerID=8YFLogxK
U2 - 10.1182/blood-2014-10-604983
DO - 10.1182/blood-2014-10-604983
M3 - Article
C2 - 25525079
AN - SCOPUS:84919493189
VL - 124
SP - 3836
EP - 3837
JO - Blood
JF - Blood
SN - 0006-4971
IS - 26
ER -